Myostatin-related muscle hypertrophy
Ultimo aggiornamento 2 Ottobre 2024
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
Myostatin-related muscle hypertrophy is a rare condition characterised by reduced body fat and increased muscle size. Affected individuals have up to twice the usual amount of muscle mass in their bodies. They also tend to have increased muscle strength. Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.
Scelte video per Condizioni geneticheVideo library
Descrizione
Myostatin-related muscle hypertrophy is a rare condition characterised by reduced body fat and increased muscle size. Affected individuals have up to twice the usual amount of muscle mass in their bodies. They also tend to have increased muscle strength. Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.
Modelli di ereditarietà
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Altri nomi
Muscle hypertrophy syndrome
Related patient information and medicines

Patient information leaflet
Posso prendere Atorvastatina e Piridostigmina insieme?
There is a potential for increased muscle-related side effects when taking these two medicines together. Both drugs can independently affect muscle function; atorvastatin can cause muscle aches or weakness (myopathy), e pyridostigmine is used to treat debolezza muscolare nel conditions like miastenia grave. Taking them together might make it harder.

Patient information leaflet
Distrofia muscolare
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, rangi... Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). These are: Muscle wasting - in.

Patient information leaflet
Posso prendere Atorvastatina e Prednisolone insieme?
Assumere atorvastatin and prednisolone insieme may increase the risk of muscle-related side effects, come tensione muscolare pain, tenderness, or weakness. In rare cases, this can lead to a serious condition called rhabdomyolysis, where muscle t... Why this happens Both medications can independently cause muscle toxicity (myopathy). Furthermore,.

Patient information leaflet
Debolezza muscolare
This leaflet looks at types of debolezza muscolare and discusses the wide range of problems which can cause them. Debolezza muscolare is a common complaint but the word weakness can mean different things to different people - including tiredness, reduced power and failure to work at all. Muscle 'fatiga... This often goes along with muscle tiredness but is.

Patient information leaflet
Posso prendere Bisoprololo e Simvastatina insieme?
There is no direct interaction between bisoprolol and simvastatin. However, both farmaci can occasionally cause muscle-related side effects, come weakness or fatigue. While... Why this happens Bisoprolol is a beta-blocker used for heart rate and blood pressure, while simvastatin is a statin used for cholesterol. Grapefruit contains a.

Patient information leaflet
Posso prendere Atorvastatina e Tamsulosina insieme?
There is no known direct interaction between atorvastatin and tamsulosin. Why this happens Atorvastatin and tamsulosin are processed by different pathways in the body and do not interfere with how the other drug works or is cl... Muscle disorders - atorvastatina Seek immediate medical advice if you experience unexplained muscle pain, tenderness, or.
Ulteriori letture e riferimenti
- Myostatin-related muscle hypertrophy; MedlinePlus, National Library of Medicine.
- Carnac G, Ricaud S, Vernus B, Bonnieu A. Myostatin: biology and clinical relevance. Mini Rev Med Chem. 2006 Jul;6(7):765-70. doi: 10.2174/138955706777698642.
- Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004 Jun 24;350(26):2682-8. doi: 10.1056/NEJMoa040933. No abstract available.
Storia dell'articolo
Articolo disponibile anche in Inglese, Tedesco, Spagnolo, Francese, Italiano, Portoghese, Hindi, Ebraico, Arabo, and Svedese.
2 Ottobre 2024 | Ultima versione
1 Dec 2008 | Pubblicato originariamente
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

